Accropeutics
Accropeutics Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for immune-mediated inflammatory diseases. The company targets molecular mechanisms of regulated cell death to create potentially best-in-class therapies for a wide range of diseases. Accropeutics has a robust portfolio of compounds in various stages of development, from lead optimization to clinical testing.
Funding Round: Series B+
Funding Amount: $12M
Date: 14-Mar-2025
Investors: Shenzhen Capital Group (SCGC), Morningside Ventures, Leader Venture Investment (SZTI), Hefei Sci-Tec Venture Capital (HFST)
Markets: Biotech, Therapeutics, Pharmaceuticals
HQ: New York, New York, United States
Founded: 2017
Website: http://www.accropeutics.com/
LinkedIn: https://www.linkedin.com/company/accro-bioscience
Crunchbase: https://www.crunchbase.com/organization/accro-bioscience
Leave a Comment
Comments
No comments yet.